The largest database of trusted experimental protocols

Model 2130

Manufactured by Cardinal Health
Sourced in United States

The Model 2130 is a compact and versatile lab equipment piece designed to perform fundamental laboratory tasks. It features a user-friendly interface and robust construction to support common laboratory operations.

Automatically generated - may contain errors

Lab products found in correlation

26 protocols using model 2130

1

Standardized Pulmonary Function Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used dry rolling seal spirometers (Model 2130; SensorMedics, Yorba Linda, CA, USA) for pulmonary function test. We accepted the spirometry results, which showed two or more acceptable curves and satisfied reproducibility criteria of American Thoracic Society/European Respiratory Society.1 (link) The spirometry data were recorded on web-hard to be examined for quality control and quality confidence.
After spirometry in KNHANES-VI, eligible subjects with normal spirometry and chest X-ray findings were asked to take part in this study.
Participants who signed the written consent moved to 16 regional university hospitals located within an hour's distance from their households to repeat the spirometry. Spirometry was re-performed by expert technicians who performed the diffusing capacity test ≥ 200 times/year for 5 years or more at the university hospitals.12 (link) All technicians had undergone quality control training.
+ Open protocol
+ Expand
2

Measuring Lung Function with Spirometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Forced expiratory volume in 1 second (FEV1) was measured using a dry rolling-seal spirometer (Model 2130; SensorMedics, Anaheim, CA, USA). American Thoracic Society recommendations were followed (32 (link)). The predicted values for FEV1 were calculated on the basis of European Coal and Steel Union reference values (33 (link),34 (link)).
+ Open protocol
+ Expand
3

Standardized Pulmonary Function Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pulmonary function was measured using a dry rolling seal spirometer (Model 2130; Sensor-Medics, Yorba Linda, CA, USA) according to the American Thoracic Society/European Respiratory Society criteria for standardization (12 (link)). Spirometric data obtained on site by clinical technicians was transferred to an internet review center for processing. The data was compared against criteria metrics for acceptability, reproducibility, and quality control. A principal investigator validated and stored the data in a KCDC repository management system. AFO is defined by a decrease of the pre-bronchodilator forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) below 70%. Severity of AFO was classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage system. Pre-bronchodilator FEV1/FVC ≥ 70% and FVC < 80% was defined as spirometric restriction.
+ Open protocol
+ Expand
4

Standardized Pulmonary Function Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spirometry was performed using dry rolling seal spirometers (Model 2130; SensorMedics, Yorba Linda, CA, USA) and the American Thoracic Society (ATS)/European Respiratory Society (ERS) criteria for the standardization of pulmonary function test18 (link). The results of spirometry in each enumeration districts were stored on web-hard to investigate whether the results satisfied acceptability and reproducibility criteria of spirometry for quality control and quality assurance. For analysis on results of spirometry, only results showing two or more acceptable curves and meeting reproducibility criteria were used17 .
+ Open protocol
+ Expand
5

Pulmonary Function Assessment via Spirometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pulmonary function was measured by clinical technicians using a dry rolling seal spirometer (model 2130; Sensor-Medics, Yorba Linda, CA, USA). Forced expiratory volume in 1 s (FEV1) and FVC measurements were performed according to the American Thoracic Society/European Respiratory Society guidelines and National Health and Nutrition Examination Survey (NHANES) method. Lung function measurements primarily included the FVC, FEV1, forced expiratory volume in 6 s (FEV6), forced expiratory flow between 25% and 75% of the FVC (FEV25–75%), and peak expiratory flow (PEF). Four criteria were applied to the spirometer data: (1) at least three acceptable spirometry curves for 6 s or more, (2) <150 mL inter-measurement variability in FVC and FEV1, (3) ≤10% inter-measurement variability in PEF, and (4) extra volume ≤5% of FVC (150 mL). Predicted spirometry values were calculated from the Korean reference equations, based on representative samples of the Korean population [15 (link)]. We used FVC, FEV1, the FEV1 to FVC ratio (FEV1/FVC), and the percentage of predicted values for FEV1 (%, FEV1p) and FVC (%, FVCp) to assess pulmonary function. A decline in the FVCp < 80% was regarded as a restrictive pattern of poor lung function [16 (link)].
+ Open protocol
+ Expand
6

Spirometric Lung Function Assessment in Koreans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung function was measured using a dry rolling seal spirometer (model 2130, SensorMedics, Yorba Linda, CA) according to the American Thoracic Society/European Respiratory Society criteria for standardization24 (link). Best forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) values were selected for data analysis. Spirometric data were obtained on site by clinical technicians. The percentage of predicted values for FEV1 and FVC were calculated from the following equations obtained in a representative Korean population25 (link). PredictedFVCinmen=4.8434(0.00008633×age2[year])+(0.05292×height[cm])+(0.01095×weight[kg])
PredictedFVCinwomen=3.0006(0.0001273×age2[year])+(0.03951×height[cm])+(0.006892×weight[kg])
PredictedFVC1inmen=3.4132(0.0002484×age2[year])+(0.04578×height[cm])
PredictedFVC1inwomen=2.4114(0.0001920×age2[year])+(0.03558×height[cm])
+ Open protocol
+ Expand
7

Standardized Spirometry Measurements in Korean Population

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described in detail previously [23 (link)], spirometry was performed using a dry rolling seal spirometer (Model 2130; Sensor Medics, Yorba Linda, CA, USA). Trained clinical technicians obtained spirometry data including FEV1, FVC, and FEV1/FVC on site and transferred them to an internet review center for processing. The data were compared against criteria metrics for acceptability, reproducibility, and quality control by a principal investigator to validate the data and to store them in a Korea Centers for Disease Control repository management system, in accordance with the ATS/ERS recommendations [1 (link)]. Two criteria were applied to the spirometry data: 1) two or more acceptable spirometry curves to ensure correct inspiration and 6s expiration and 2) 150-ml inter-measurement variability in FVC and FEV1. The spirometry tests were undertaken without the use of a bronchodilator. Age-, sex-, and height-adjusted normal predicted values of FVC and FEV1 in the general Korean population were used to calculate the values of percent-predicted FVC and FEV1.
+ Open protocol
+ Expand
8

Measuring Lung Function: FEV1 Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Forced expiratory volume in one second (FEV1) was measured in ECRHS II using a dry rolling‐seal spirometer (Model 2130; SensorMedics, Anaheim, Cal, USA). Up to five technically acceptable manoeuvres were measured. American Thoracic Society recommendations were followed.33 The predicted values for FEV1 were calculated on the basis of European Coal and Steel Union reference values.34 Weight and height were measured, and body mass index (BMI) was calculated.
+ Open protocol
+ Expand
9

Spirometric Evaluation of Lung Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spirometry was performed by 4 technicians using a dry rolling seal spirometer (Model 2130; SensorMedics, Yorba Linda, CA, USA), and spirometric prediction equations were derived from survey data on non-smokers with normal chest X-ray findings and no history of respiratory disease or symptoms [11 (link)]. Using data on forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC), participants were classified into restrictive lung disease or COPD groups according to the severity of COPD based on the definition of the Global Initiative for COPD; normal (FEV1/FVC ≥0.7 and percent-predicted FVC [FVCp] ≥80%), restrictive (FEV1/FVC ≥0.7 and FVCp <80%), mild obstruction (FEV1/FVC <0.7 and percent predicted FEV1 [FEV1p] ≥80%), moderate obstruction (FEV1/FVC <0.7 and 50 ≤FEV1p <80%), and severe and very severe obstruction (FEV1/FVC <0.7 and FEV1p <50%) [7 (link),12 (link)].
+ Open protocol
+ Expand
10

Standardized Spirometry Measurements and Predictive Modeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spirometry was performed using a dry rolling seal spirometer (Model 2130; Sensor Medics, Yorba Linda, CA, USA). Spirometric indices including FEV1, FVC, and FEV1/FVC were measured and evaluated in accordance with the ATS/ERS recommendations for standardized lung function and the criteria of acceptability and repeatability for spirometry.2 (link) In the KNHANES IV, spirometry was performed for adults aged 19 years and over, while adults aged 40 years and over were measured in the KNHANES V.
Age, sex, and height data of all subjects were collected to develop models for outcome variables. Weight was not considered because regression effects make it inappropriate to predict pulmonary function using body mass within mammal species.14 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!